GSTM1 and Cirrhosis: When compared with 2019, patients during COVID-19 pandemic in 2020 were significantly older (years) (62.1 vs 68.3, P < .01), required longer hospital length of stay (days) (11.3 vs 20.9, P < .01; Table 1), had higher rate of mortality (12.5% vs 36%, P < .01), were less likely to have a history of cirrhosis (25.8% vs 6.6%, P < .01), presented with a higher Hb (mL/dL) (9.9 vs 11.9, P < .001), and were less likely to undergo EGD (58.4% vs 13.2%, P < .001) or colonoscopy (21.6% vs 4%, P < .01).